Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
FXG vs RSPS: Comparing Two Distinct Approaches to Consumer Staples Exposure

FXG vs RSPS: Comparing Two Distinct Approaches to Consumer Staples Exposure

Key Takeaways

  • Different weighting philosophies: FXG uses a multi-factor AlphaDEX selection model, while RSPS equal-weights S&P 500 consumer staples constituents.
  • Cost gap: RSPS charges a 0.40% expense ratio, notably cheaper than FXG's 0.63%.
  • Exposure purity: FXG drifts into healthcare and consumer cyclical names, whereas RSPS remains nearly fully invested in consumer staples.
  • Diversification profile: RSPS caps every holding near 3%, reducing single-name concentration relative to FXG's factor-driven tilts.
  • Risk and volatility: Both funds carry low betas, but FXG's mid-cap factor exposure introduces a different risk profile.
  • Tickeron AI Verdict: RSPS is favored for its lower cost, purer sector exposure, and more evenly diversified portfolio.

Why These Two ETFs Stand Out

Consumer staples are often viewed as a straightforward defensive allocation, yet two funds targeting the same broad sector can deliver noticeably different results. FXG and RSPS both aim to provide defensive, dividend-oriented equity exposure, but they follow contrasting index-construction methods. One relies on a quantitative factor screen intended to uncover potential outperformance, while the other applies straightforward equal weighting across S&P 500 staples names. For investors considering sector exposure, these structural details matter more than short-term price movements. I also checked this using Tickeron’s AI Screener to see how the two funds compare on key metrics.

First Trust Consumer Staples AlphaDEX Fund (FXG) Overview

FXG tracks the StrataQuant Consumer Staples Index, which applies First Trust's AlphaDEX methodology to select and rank stocks from the Russell 1000 consumer staples universe. The process blends growth and value factors to tilt toward names the model anticipates will outperform. Launched in May 2007, the fund holds roughly 41 securities and carries a 0.63% expense ratio. Because the index re-ranks periodically, the portfolio can extend beyond traditional staples. Recent top holdings include BG, MCK, SFD, PPC, and GIS. Sector allocation sits near 79% consumer defensive, with about 13% in healthcare and smaller positions in consumer cyclical and industrial names. Large-caps account for roughly half the assets, with a notable mid-cap component.

Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) Overview

RSPS follows the S&P 500 Equal Weight Consumer Staples Index, assigning roughly equal weights to every consumer staples constituent of the S&P 500 and rebalancing quarterly. Launched in November 2006, the fund holds about 39 stocks and charges a 0.40% expense ratio. Equal weighting limits dominance by mega-cap names and gives mid-sized staples companies more proportional influence. Recent top holdings include MNST, TGT, KR, COST, and WMT, each typically near 3% of assets. The portfolio stays almost entirely in consumer staples—over 90%—with minimal spillover into cyclicals and a large-cap focus that delivers a cleaner sector allocation.

The Broader Consumer Staples Landscape

Consumer staples operate amid several macro pressures. Ongoing inflation and higher borrowing costs have strained household budgets, pushing shoppers toward value options and pressuring premium brands. At the same time, the sector’s low-beta and cash-generative qualities draw investors seeking stability amid equity volatility. Longer-term factors such as GLP-1 weight-loss drugs, changing consumption habits, and private-label competition pose structural challenges to packaged-food and beverage companies. In this environment, differences in portfolio construction can influence outcomes as much as the sector choice itself.

Performance and Positioning Comparison

Over recent market cycles, the funds have diverged in line with their construction approaches. RSPS’s equal-weight, staples-only design has generally followed the sector’s defensive rotation more closely, aided by quarterly rebalancing that trims winners and adds to laggards. FXG’s factor screen introduces additional style exposure through its healthcare and mid-cap tilt, so performance can reflect earnings trends outside core staples. FXG’s lower beta and value tilt can provide support in risk-off periods, yet its higher fee and less-pure sector profile add uncertainty to relative results. The cost difference tends to favor RSPS over longer holding periods.

Using Tickeron Tools in My Analysis

When comparing sector ETFs like these, I find Tickeron’s AI Screener helpful for quickly scanning holdings, volatility metrics, and performance patterns across similar funds. It lets me apply customizable filters to highlight how construction differences show up in real time, which adds useful context to the structural review above.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FXG, RSPS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FXG sees MACD Histogram crosses below signal line

FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Kroger Co (The) (NYSE:KR), Archer Daniels Midland Company (NYSE:ADM), Constellation Brands (NYSE:STZ).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Consumer Staples Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the consumer staples sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF is 51.47B. The market cap for tickers in the group ranges from 3.09B to 411.62B. KO holds the highest valuation in this group at 411.62B. The lowest valued company is FRPT at 3.09B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was -3%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 2%. TSN experienced the highest price growth at 11%, while BG experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 57% and the average quarterly volume growth was 49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 48
Price Growth Rating: 47
SMR Rating: 59
Profit Risk Rating: 69
Seasonality Score: 10 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.